Patients in other countries are getting access to breakthrough cancer drugs faster than Aussies

11 November 2020 - Old news and hardly an exclusive. ...

Read more →

‘It really seems cruel’: drug giant’s brutal blow to Australian breast cancer patients

21 October 2020 - Terminally ill breast cancer patients will have to pay $1,600 a month for a lifesaving treatment, after ...

Read more →

Hope for ovarian cancer patients with new drug listed on PBS

6 October 2020 - Hundreds of Australian patients with ovarian cancer are being given affordable access to a groundbreaking drug ...

Read more →

Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease

4 October 2020 - In Tuesday’s Budget, the Morrison Government will provide significant investment for new medicines including over $230 million ...

Read more →

The mother of three on her last chance to beat blood cancer

2 September 2020 - Deb Sims knows she’s on her last chance to beat the blood cancer that has dogged ...

Read more →

New hope for Australian leukaemia and lymphoma patients with key treatment option listed on PBS

31 August 2020 - A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia ...

Read more →

Prostate cancer treatment Nubeqa made available for free in Australia by Bayer

23 August 2020 - Prostate cancer kills more than 3,000 men a year in Australia. But now many will have access ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2020

 1 August 2020 - The August 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Australians with cancer, infants with epilepsy to benefit from PBS listings

1 August 2020 - Australians with certain cancers and infants with severe epilepsy will benefit from new medications being listed or ...

Read more →

PBAC asks Roche for another comparison for Tecentriq

20 July 2020 - The submission requested a PBS (Section 100) listing for atezolizumab for use in combination with taxane chemotherapy ...

Read more →

Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE

13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...

Read more →

New combination therapy now reimbursed for Australians living with incurable blood cancer

 1 June 2020 - New combination therapy now reimbursed for Australians living with incurable blood cancer. ...

Read more →

Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy

1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging.  ...

Read more →

Blood cancer treatment added to PBS

1 April 2020 - Nearly a decade after doctors told him he had up to six years to live, Ian ...

Read more →

Government strengthens support for melanoma patients with breakthrough treatment expanded on PBS

1 March 2020 - The start of autumn will bring with it a new sense of hope for over 2,000 Australians ...

Read more →